Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.

about

Vitamin D and bone loss in HIV Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: a multicenter retrospective cohort study from 2007 to 2015.

P2860

Q36816930-59BC2A96-B4AB-4AFA-9501-2BEB8E988379 Q55512944-99869407-B520-4F41-BAAB-211F83C1A417

P2860

Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.

Item

http://www.wikidata.org/entity/Q40874258

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Associations between vitamin D ...... al density in people with HIV.

@en

type

Item

label

Associations between vitamin D ...... al density in people with HIV.

@en

prefLabel

Associations between vitamin D ...... al density in people with HIV.

@en

P1476

Associations between vitamin D ...... al density in people with HIV.

@en

P2093

K M Klassen

http://www.w3.org/2001/XMLSchema#string

P H Anderson

http://www.w3.org/2001/XMLSchema#string

P R Ebeling

http://www.w3.org/2001/XMLSchema#string

STEAL Study Group

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know

The effect of tenofovir on vitamin D metabolism in HIV-infected adults is dependent on sex and ethnicity

Body size from birth to adulthood and bone mineral content and density at 31 years of age: results from the northern Finland 1966 birth cohort study.

Short-term bone loss in HIV-infected premenopausal women

Short communication: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users

A pooled analysis of vitamin D dose requirements for fracture prevention.

Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study.

Bone mass and mineral metabolism in HIV+ postmenopausal women.

Relationship of obesity with osteoporosis.

P2888

s00198-015-3432-3

P304

1737-1745

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00198-015-3432-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christopher K. Fairley

Sean Emery

Michael G. Kimlin

P577

2015-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1034931589

http://www.w3.org/2001/XMLSchema#string

P698

26659069

http://www.w3.org/2001/XMLSchema#string

P921

vitamin D

antiretroviral drug

Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.

about

P2860

P2860

Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921